Trending
April 8, 2024 Flagship Appoints Amy O’Shea as CEO-Partner and Chief Executive Officer of Invaio SciencesMarch 25, 2024 Sirtex Medical Appoints Matt Schmidt as Chief Executive OfficerMarch 18, 2024 Syndax Appoints Steven Closter as Chief Commercial OfficerMarch 6, 2024 Sionna Therapeutics Closes $182 Million Series C FinancingMarch 5, 2024 Interview with Steve Holtzclaw, CEO at U.S. Orthopaedic Partners
Featured
April 8, 2024
Flagship Appoints Amy O’Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences
Flagship Pioneering, the bioplatform innovation company, and Invaio Sciences, a bioplatform company accelerating the... Read more »
March 25, 2024
Sirtex Medical Appoints Matt Schmidt as Chief Executive Officer
Sirtex Medical, a leading manufacturer of interventional treatment solutions, announced today the appointment of Matt... Read more »
March 18, 2024
Syndax Appoints Steven Closter as Chief Commercial Officer
Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of... Read more »
